Literature DB >> 19915868

Monoamine oxidase A gene polymorphisms and enzyme activity associated with risk of gout in Taiwan aborigines.

Hung-Pin Tu1, Albert Min-Shan Ko, Shu-Jung Wang, Chien-Hung Lee, Rod A Lea, Shang-Lun Chiang, Hung-Che Chiang, Tsu-Nai Wang, Meng-Chuan Huang, Tsan-Teng Ou, Gau-Tyan Lin, Ying-Chin Ko.   

Abstract

Taiwanese aborigines have a high prevalence of hyperuricemia and gout. Uric acid levels and urate excretion have correlated with dopamine-induced glomerular filtration response. MAOs represent one of the major renal dopamine metabolic pathways. We aimed to identify the monoamine oxidase A (MAOA, Xp11.3) gene variants and MAO-A enzyme activity associated with gout risk. This study was to investigate the association between gout and the MAOA single-nucleotide polymorphisms (SNPs) rs5953210, rs2283725, and rs1137070 as well as between gout and the COMT SNPs rs4680 Val158Met for 374 gout cases and 604 controls. MAO-A activity was also measured. All three MAOA SNPs were significantly associated with gout. A synonymous MAOA SNP, rs1137070 Asp470Asp, located in exon 14, was associated with the risk of having gout (P = 4.0 x 10(-5), adjusted odds ratio 1.46, 95% confidence intervals [CI]: 1.11-1.91). We also showed that, when compared to individuals with the MAOA GAT haplotype, carriers of the AGC haplotype had a 1.67-fold (95% CI: 1.28-2.17) higher risk of gout. Moreover, we found that MAOA enzyme activity correlated positively with hyperuricemia and gout (P for trend = 2.00 x 10(-3) vs. normal control). We also found that MAOA enzyme activity by rs1137070 allele was associated with hyperuricemia and gout (P for trend = 1.53 x 10(-6) vs. wild-type allele). Thus, our results show that some MAOA alleles, which have a higher enzyme activity, predispose to the development of gout.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19915868     DOI: 10.1007/s00439-009-0765-z

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  27 in total

1.  Gout, diuretics and the kidney.

Authors:  E Pascual; M Perdiguero
Journal:  Ann Rheum Dis       Date:  2006-08       Impact factor: 19.103

Review 2.  Redox modulation of tyrosine phosphorylation-dependent signal transduction pathways.

Authors:  H P Monteiro; A Stern
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

Review 3.  Molecular physiology of urate transport.

Authors:  Matthias A Hediger; Richard J Johnson; Hiroki Miyazaki; Hitoshi Endou
Journal:  Physiology (Bethesda)       Date:  2005-04

Review 4.  The management of gout.

Authors:  B T Emmerson
Journal:  N Engl J Med       Date:  1996-02-15       Impact factor: 91.245

5.  Reactive oxygen species production by monoamine oxidases in intact cells.

Authors:  N Pizzinat; N Copin; C Vindis; A Parini; C Cambon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1999-05       Impact factor: 3.000

6.  Activation of pro-apoptotic cascade by dopamine in renal epithelial cells is fully dependent on hydrogen peroxide generation by monoamine oxidases.

Authors:  Pascale Bianchi; Marie-Hélène Séguélas; Angelo Parini; Claudie Cambon
Journal:  J Am Soc Nephrol       Date:  2003-04       Impact factor: 10.121

Review 7.  The renal dopamine receptors.

Authors:  P A Jose; J R Raymond; M D Bates; A Aperia; R A Felder; R M Carey
Journal:  J Am Soc Nephrol       Date:  1992-02       Impact factor: 10.121

8.  Complex segregation and linkage analysis of familial gout in Taiwanese aborigines.

Authors:  Wen Hsin Wang; Shun Jen Chang; Tsu Nai Wang; Li Shu-Chuan Cheng; Yu Ping Feng; Chung Jen Chen; Chun Hsiung Huang; Ying Chin Ko
Journal:  Arthritis Rheum       Date:  2004-01

9.  Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.

Authors:  Naohiko Anzai; Kimiyoshi Ichida; Promsuk Jutabha; Toru Kimura; Ellappan Babu; Chun Ji Jin; Sunena Srivastava; Kenichiro Kitamura; Ichiro Hisatome; Hitoshi Endou; Hiroyuki Sakurai
Journal:  J Biol Chem       Date:  2008-08-13       Impact factor: 5.157

10.  Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA.

Authors:  O Cases; I Seif; J Grimsby; P Gaspar; K Chen; S Pournin; U Müller; M Aguet; C Babinet; J C Shih
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

View more
  6 in total

1.  Gout in males: a possible role for COMT hypomethylation.

Authors:  Xiuru Ying; Yanfei Chen; Zhonghua Zheng; Shiwei Duan
Journal:  Clin Rheumatol       Date:  2019-06-04       Impact factor: 2.980

2.  ALPK1 genetic regulation and risk in relation to gout.

Authors:  Albert Min-Shan Ko; Hung-Pin Tu; Tze-Tze Liu; Jan-Gowth Chang; Chung-Yee Yuo; Shang-Lun Chiang; Shun-Jen Chang; Yu-Fan Liu; Allen Min-Jen Ko; Chien-Hung Lee; Chi-Pin Lee; Chung-Ming Chang; Shih-Feng Tsai; Ying-Chin Ko
Journal:  Int J Epidemiol       Date:  2013-04       Impact factor: 7.196

3.  An association study on renalase polymorphisms and ischemic stroke in a Chinese population.

Authors:  Ruyou Zhang; Xiaoying Li; Nana Liu; Xijuan Guo; Wei Liu; Chunping Ning; Zhenzhen Wang; Litao Sun; Songbin Fu
Journal:  Neuromolecular Med       Date:  2013-04-06       Impact factor: 3.843

4.  Common Variants in LRP2 and COMT Genes Affect the Susceptibility of Gout in a Chinese Population.

Authors:  Zheng Dong; Dongbao Zhao; Chengde Yang; Jingru Zhou; Qiaoxia Qian; Yanyun Ma; Hongjun He; Hengdong Ji; Yajun Yang; Xiaofeng Wang; Xia Xu; Yafei Pang; Hejian Zou; Li Jin; Jiucun Wang
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

Review 5.  Multiple Membrane Transporters and Some Immune Regulatory Genes are Major Genetic Factors to Gout.

Authors:  Weifeng Zhu; Yan Deng; Xiaodong Zhou
Journal:  Open Rheumatol J       Date:  2018-07-24

6.  Roles of Hostility and Depression in the Association between the MAOA Gene Polymorphism and Internet Gaming Disorder.

Authors:  Ju-Yu Yen; Wei-Po Chou; Huang-Chi Lin; Hung-Chi Wu; Wen-Xiang Tsai; Chih-Hung Ko
Journal:  Int J Environ Res Public Health       Date:  2021-06-27       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.